1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Pulmonary Devices Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Pulmonary Devices Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Pulmonary Devices Market Regional Analysis
6.2 North America Pulmonary Devices Market Revenue 2017-2027 (US$ Million)
6.3 North America Pulmonary Devices Market Forecast Analysis
7. North America Pulmonary Devices Market Analysis – by Type
7.1 Therapeutic Devices
- 7.1.1 Overview
- 7.1.2 Therapeutic Devices: North America Pulmonary Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Consumables and Accessories
- 7.2.1 Overview
- 7.2.2 Consumables and Accessories: North America Pulmonary Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Diagnostic Devices
- 7.3.1 Overview
- 7.3.2 Diagnostic Devices: North America Pulmonary Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Monitoring Devices
- 7.4.1 Overview
- 7.4.2 Monitoring Devices: North America Pulmonary Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. North America Pulmonary Devices Market Analysis – by Application
8.1 Chronic Obstructive Pulmonary Disease
- 8.1.1 Overview
- 8.1.2 Chronic Obstructive Pulmonary Disease: North America Pulmonary Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Sleep Apnea
- 8.2.1 Overview
- 8.2.2 Sleep Apnea: North America Pulmonary Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Asthma
- 8.3.1 Overview
- 8.3.2 Asthma: North America Pulmonary Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Infectious Diseases
- 8.4.1 Overview
- 8.4.2 Infectious Diseases: North America Pulmonary Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. North America Pulmonary Devices Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Pulmonary Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Homecare Settings
- 9.2.1 Overview
- 9.2.2 Homecare Settings: North America Pulmonary Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Ambulatory Care Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory Care Centers: North America Pulmonary Devices Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. North America Pulmonary Devices Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Pulmonary Devices Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.2.1.1 North America Pulmonary Devices Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Pulmonary Devices Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 US: North America Pulmonary Devices Market Breakdown, by Type
- 10.2.1.1.2 US: North America Pulmonary Devices Market Breakdown, by Application
- 10.2.1.1.3 US: North America Pulmonary Devices Market Breakdown, by End User
- 10.2.1.2 Canada:
North America Pulmonary Devices Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Canada: North America Pulmonary Devices Market Breakdown, by Type
- 10.2.1.2.2 Canada: North America Pulmonary Devices Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America Pulmonary Devices Market Breakdown, by End User
- 10.2.1.3 Mexico :
North America Pulmonary Devices Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 Mexico : North America Pulmonary Devices Market Breakdown, by Type
- 10.2.1.3.2 Mexico : North America Pulmonary Devices Market Breakdown, by Application
- 10.2.1.3.3 Mexico : North America Pulmonary Devices Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 ResMed
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Masimo
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Invacare Corporation
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Koninklijke Philips N.V.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Getinge AB
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations